| Value | ₹119.5 Cr |
|---|
NSE filing, NSE: ZOTA. Summary written from the filing by ALFA Finder's alert engine.
Zota Healthcare Ltd: key numbers
- Share price
- ₹1,271.10
- Market cap
- ₹4,402 Cr
- Revenue (annual)
- ₹538.7 Cr
- Net profit (annual)
- ₹-73.94 Cr
- P/E (TTM)
- -39.0×Sector 46.1×
- Promoter holding
- 49.38%+0.00% QoQ
- FII holding
- 6.92%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Zota Healthcare Ltd
All →Zota Healthcare Results Update
Zota Health Care reported Q2FY27 consolidated revenue up 54.58% YoY and positive EBITDA of ₹791.72 lakhs. The Davaindia network reached 2,840 stores.
Zota Healthcare Q2 FY27 Results: Net Loss of ₹26 Cr, Loss Widens
Zota Healthcare Ltd reported revenue from operations of ₹199.3 Cr (+54.6% YoY) and a net loss of ₹26 Cr for Q2 FY27.
- Key figure
- Net loss ₹26 Cr
Zota Healthcare Board Meeting Date
Zota Health Care will hold a board meeting on October 28, 2026. The meeting will consider the company's half-yearly unaudited financial results.
Zota Healthcare Price Movement Clarification
Zota Health Care Limited clarified to the NSE that the recent increase in its share volume is market-driven, with no undisclosed material information or impending announcements.
Zota Healthcare Business Update
Zota Health Care updated its store count for Q2FY27, reporting 2,840 total stores as of September 30, 2026, after opening 20 new outlets during the quarter.
- store expansion
- 20.0 stores
Zota Healthcare Capital Structure Change
Zota Health Care Limited acquired 21,00,000 equity shares of its subsidiary, KMHP Ventures Limited, for ₹2.10 Crore. This investment supports the expansion of the 'Ugo Generic' retail pharmacy chain.
- Value
- ₹2.10 Cr
Other merger & restructuring announcements
All →Quint Digital Merger & Restructuring
Quint Digital's board approved a Rule 10b5-1 trading plan and the incorporation of a wholly owned overseas subsidiary. No investment amount was disclosed.
Hexaware Technologies Merger & Restructuring
Hexaware Technologies approved a slump sale of its step-down subsidiary Tech SMC Square India to Tech SMC Squared (GCC) India, a related-party deal. Consideration is cash, yet to be set by a registered valuer.
- Execution
- Expected completion by 30 June 2027; agreement date stated as 1 December 2026
Emkay Global Financial Services Merger & Restructuring Worth ₹2.75 Cr
Emkay Global agreed to sell its Wealth Management Business to a step-down subsidiary, Emkay Wealth Advisory, for Rs. 2.75 Crore cash. Completion is expected by 26 January 2027.
- Value
- ₹2.75 Cr
- Execution
- Completion expected by 26 January 2027
TVS Holdings Merger & Restructuring
TVS Holdings forwarded TVS Motor's board outcome of October 28, 2026 approving acquisition of Harita ARC and a composite scheme of amalgamation and demerger. The scheme is subject to stock exchange, SEBI, NCLT and shareholder approvals.
Emkay Global Financial Services Merger & Restructuring Worth ₹30 Cr
Emkay Global approved transferring two subsidiaries to new subsidiary ECPL and slump-selling its wealth business. Up to Rs.30 Crore rights investment in ECPL was also approved.
- Value
- ₹30.00 Cr
- Execution
- Divestment completion expected within 90 days of SPA execution, subject to regulatory approvals
Fortis Healthcare Merger & Restructuring Worth ₹277 Cr
Fortis subsidiary International Hospital acquired Suguna Ramaiah Hospitals' business, operations, land and building for Rs 277 Crore cash. The deal was consummated today, strengthening Bengaluru presence.
- Value
- ₹277.0 Cr